High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study.

<h4>Unlabelled</h4>Hepatitis C virus reinfection and spontaneous clearance of reinfection were examined in a highly characterised cohort of 188 people who inject drugs over a five-year period. Nine confirmed reinfections and 17 possible reinfections were identified (confirmed reinfection...

Full description

Bibliographic Details
Main Authors: Rachel Sacks-Davis, Campbell K Aitken, Peter Higgs, Tim Spelman, Alisa E Pedrana, Scott Bowden, Mandvi Bharadwaj, Usha K Nivarthi, Vijayaprakash Suppiah, Jacob George, Jason Grebely, Heidi E Drummer, Margaret Hellard
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24244654/pdf/?tool=EBI
id doaj-69d3f6c371274168910dd797fe18d11d
record_format Article
spelling doaj-69d3f6c371274168910dd797fe18d11d2021-03-04T10:16:31ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-01811e8021610.1371/journal.pone.0080216High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study.Rachel Sacks-DavisCampbell K AitkenPeter HiggsTim SpelmanAlisa E PedranaScott BowdenMandvi BharadwajUsha K NivarthiVijayaprakash SuppiahJacob GeorgeJason GrebelyHeidi E DrummerMargaret Hellard<h4>Unlabelled</h4>Hepatitis C virus reinfection and spontaneous clearance of reinfection were examined in a highly characterised cohort of 188 people who inject drugs over a five-year period. Nine confirmed reinfections and 17 possible reinfections were identified (confirmed reinfections were those genetically distinct from the previous infection and possible reinfections were used to define instances where genetic differences between infections could not be assessed due to lack of availability of hepatitis C virus sequence data). The incidence of confirmed reinfection was 28.8 per 100 person-years (PY), 95%CI: 15.0-55.4; the combined incidence of confirmed and possible reinfection was 24.6 per 100 PY (95%CI: 16.8-36.1). The hazard of hepatitis C reinfection was approximately double that of primary hepatitis C infection; it did not reach statistical significance in confirmed reinfections alone (hazard ratio [HR]: 2.45, 95%CI: 0.87-6.86, p=0.089), but did in confirmed and possible hepatitis C reinfections combined (HR: 1.93, 95%CI: 1.01-3.69, p=0.047) and after adjustment for the number of recent injecting partners and duration of injecting. In multivariable analysis, shorter duration of injection (HR: 0.91; 95%CI: 0.83-0.98; p=0.019) and multiple recent injecting partners (HR: 3.12; 95%CI: 1.08-9.00, p=0.035) were independent predictors of possible and confirmed reinfection. Time to spontaneous clearance was shorter in confirmed reinfection (HR: 5.34, 95%CI: 1.67-17.03, p=0.005) and confirmed and possible reinfection (HR: 3.10, 95%CI: 1.10-8.76, p-value=0.033) than primary infection. Nonetheless, 50% of confirmed reinfections and 41% of confirmed or possible reinfections did not spontaneously clear.<h4>Conclusions</h4>Hepatitis C reinfection and spontaneous clearance of hepatitis C reinfection were observed at high rates, suggesting partial acquired natural immunity to hepatitis C virus. Public health campaigns about the risks of hepatitis C reinfection are required.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24244654/pdf/?tool=EBI
collection DOAJ
language English
format Article
sources DOAJ
author Rachel Sacks-Davis
Campbell K Aitken
Peter Higgs
Tim Spelman
Alisa E Pedrana
Scott Bowden
Mandvi Bharadwaj
Usha K Nivarthi
Vijayaprakash Suppiah
Jacob George
Jason Grebely
Heidi E Drummer
Margaret Hellard
spellingShingle Rachel Sacks-Davis
Campbell K Aitken
Peter Higgs
Tim Spelman
Alisa E Pedrana
Scott Bowden
Mandvi Bharadwaj
Usha K Nivarthi
Vijayaprakash Suppiah
Jacob George
Jason Grebely
Heidi E Drummer
Margaret Hellard
High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study.
PLoS ONE
author_facet Rachel Sacks-Davis
Campbell K Aitken
Peter Higgs
Tim Spelman
Alisa E Pedrana
Scott Bowden
Mandvi Bharadwaj
Usha K Nivarthi
Vijayaprakash Suppiah
Jacob George
Jason Grebely
Heidi E Drummer
Margaret Hellard
author_sort Rachel Sacks-Davis
title High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study.
title_short High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study.
title_full High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study.
title_fullStr High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study.
title_full_unstemmed High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study.
title_sort high rates of hepatitis c virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description <h4>Unlabelled</h4>Hepatitis C virus reinfection and spontaneous clearance of reinfection were examined in a highly characterised cohort of 188 people who inject drugs over a five-year period. Nine confirmed reinfections and 17 possible reinfections were identified (confirmed reinfections were those genetically distinct from the previous infection and possible reinfections were used to define instances where genetic differences between infections could not be assessed due to lack of availability of hepatitis C virus sequence data). The incidence of confirmed reinfection was 28.8 per 100 person-years (PY), 95%CI: 15.0-55.4; the combined incidence of confirmed and possible reinfection was 24.6 per 100 PY (95%CI: 16.8-36.1). The hazard of hepatitis C reinfection was approximately double that of primary hepatitis C infection; it did not reach statistical significance in confirmed reinfections alone (hazard ratio [HR]: 2.45, 95%CI: 0.87-6.86, p=0.089), but did in confirmed and possible hepatitis C reinfections combined (HR: 1.93, 95%CI: 1.01-3.69, p=0.047) and after adjustment for the number of recent injecting partners and duration of injecting. In multivariable analysis, shorter duration of injection (HR: 0.91; 95%CI: 0.83-0.98; p=0.019) and multiple recent injecting partners (HR: 3.12; 95%CI: 1.08-9.00, p=0.035) were independent predictors of possible and confirmed reinfection. Time to spontaneous clearance was shorter in confirmed reinfection (HR: 5.34, 95%CI: 1.67-17.03, p=0.005) and confirmed and possible reinfection (HR: 3.10, 95%CI: 1.10-8.76, p-value=0.033) than primary infection. Nonetheless, 50% of confirmed reinfections and 41% of confirmed or possible reinfections did not spontaneously clear.<h4>Conclusions</h4>Hepatitis C reinfection and spontaneous clearance of hepatitis C reinfection were observed at high rates, suggesting partial acquired natural immunity to hepatitis C virus. Public health campaigns about the risks of hepatitis C reinfection are required.
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24244654/pdf/?tool=EBI
work_keys_str_mv AT rachelsacksdavis highratesofhepatitiscvirusreinfectionandspontaneousclearanceofreinfectioninpeoplewhoinjectdrugsaprospectivecohortstudy
AT campbellkaitken highratesofhepatitiscvirusreinfectionandspontaneousclearanceofreinfectioninpeoplewhoinjectdrugsaprospectivecohortstudy
AT peterhiggs highratesofhepatitiscvirusreinfectionandspontaneousclearanceofreinfectioninpeoplewhoinjectdrugsaprospectivecohortstudy
AT timspelman highratesofhepatitiscvirusreinfectionandspontaneousclearanceofreinfectioninpeoplewhoinjectdrugsaprospectivecohortstudy
AT alisaepedrana highratesofhepatitiscvirusreinfectionandspontaneousclearanceofreinfectioninpeoplewhoinjectdrugsaprospectivecohortstudy
AT scottbowden highratesofhepatitiscvirusreinfectionandspontaneousclearanceofreinfectioninpeoplewhoinjectdrugsaprospectivecohortstudy
AT mandvibharadwaj highratesofhepatitiscvirusreinfectionandspontaneousclearanceofreinfectioninpeoplewhoinjectdrugsaprospectivecohortstudy
AT ushaknivarthi highratesofhepatitiscvirusreinfectionandspontaneousclearanceofreinfectioninpeoplewhoinjectdrugsaprospectivecohortstudy
AT vijayaprakashsuppiah highratesofhepatitiscvirusreinfectionandspontaneousclearanceofreinfectioninpeoplewhoinjectdrugsaprospectivecohortstudy
AT jacobgeorge highratesofhepatitiscvirusreinfectionandspontaneousclearanceofreinfectioninpeoplewhoinjectdrugsaprospectivecohortstudy
AT jasongrebely highratesofhepatitiscvirusreinfectionandspontaneousclearanceofreinfectioninpeoplewhoinjectdrugsaprospectivecohortstudy
AT heidiedrummer highratesofhepatitiscvirusreinfectionandspontaneousclearanceofreinfectioninpeoplewhoinjectdrugsaprospectivecohortstudy
AT margarethellard highratesofhepatitiscvirusreinfectionandspontaneousclearanceofreinfectioninpeoplewhoinjectdrugsaprospectivecohortstudy
_version_ 1714806455965581312